Source: PR NEWSWIRE

Press Release: Aryogen : Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight Report

DUBLIN, Apr. 02, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/5mz2d2/non_hodgkin) has announced the addition of the "Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight" report to their offering. The market for Non Hodgkin Lymphoma...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Mohammad Saffarioun's photo - CEO of AryoGen Pharmed

CEO

Mohammad Saffarioun

CEO Approval Rating

67/100

Read more